Table 2.
Cox proportional hazards analysis for risk factors associated with local tumor progression after RFA (n = 176)
Factors | Univariate analysis | Multivariate analysis |
---|---|---|
P value (HR, 95% CI) | P value (HR, 95% CI) | |
Age | 0.38 | |
HCV antibody positive | 0.28 | |
HCV RNA status (SVR) | 0.59 | |
HBs antigen positive | 0.44 | |
HBc antibody positive | 0.47 | |
Platelet counts (×103/μL) | 0.67 | |
Serum albumin level (g/dL) | 0.46 | |
Serum total bilirubin level (g/dL) | 0.65 | |
Prothrombin time (%) | 0.77 | |
AFP level (ng/mL) | 0.49 | |
AFP‐L3 index >10% | 0.002 (5.10, 1.81–14.3) | 0.002 (5.10, 1.82–14.3) |
DCP level (mAU/mL) | 0.54 | |
Tumor size (cm) | 0.19 | |
MFI irregular pattern | 0.027 (5.38, 1.21–23.8) | 0.025 (5.46, 1.23–24.4) |
HR, hazard ratio; CI, confidence interval; SVR, sustained viral response; DCP, des‐gamma‐carboxy prothrombin.